AVEO Pharma (AVEO) Reports Publication of Positive Bivozanib Phase 2 Data; Will Submit NDA in Q312

Go back to AVEO Pharma (AVEO) Reports Publication of Positive Bivozanib Phase 2 Data; Will Submit NDA in Q312